Guardant Health Inc
Research Guardant Health Inc (GH) on Bullrun: market cap USD 20.39B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerGH
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryDiagnostics & Research
- CurrencyUSD
- Market capUSD 20.39B
- Financial periodFY2025
- RevenueUSD 982.02M
- Revenue growth32.9%
- Net income-USD 416.30M
- Free cash flow-USD 233.07M
- Gross margin64.5%
Valuation Snapshot
latest market cap is USD 20.39B.
About Guardant Health Inc
Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, and data sets in the United States and internationally. The company offers Guardant360 CDx test, a liquid biopsy test for tumor mutation profiling; Guardant360 Liquid test, which measures 740+ genes and supports all guideline-recommended biomarkers; Guardant Reveal test, a blood test that utilizes circulating tumor DNA to detect cancer at the molecular level;
Frequently asked questions
What is Guardant Health Inc's market cap?
Guardant Health Inc's market capitalization is USD 20.39B.
What does Guardant Health Inc do?
Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, and data sets in the United States and internationally. The company offers Guardant360 CDx test, a liquid biopsy test for tumor mutation profiling;